Cargando…
In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells
OBJECTIVE: The acute cases of pneumonia (COVID-19) were first reported from China in December 2019, and the pathogen was identified as SARS-CoV-2. Currently, many vaccines have been developed against this virus by using multiple genes, applying different platforms, and used for the vaccinations of t...
Autores principales: | Sartaj Sohrab, Sayed, Aly El-Kafrawy, Sherif, Ibraheem Azhar, Esam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040457/ https://www.ncbi.nlm.nih.gov/pubmed/35493709 http://dx.doi.org/10.1016/j.jksus.2022.102049 |
Ejemplares similares
-
In silico prediction and experimental validation of siRNAs targeting ORF1ab of MERS-CoV in Vero cell line
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2021) -
Delivery of siRNAs against MERS-CoV in Vero and HEK-293 cells: A comparative evaluation of transfection reagents
por: Sartaj Sohrab, Sayed, et al.
Publicado: (2023) -
Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2022) -
Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2021) -
In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells
por: El-Kafrawy, Sherif Aly, et al.
Publicado: (2021)